MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
LivaNova PLC Retained Earnings 2011-2026 | LIVN
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings LivaNova PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.15 B | -903 M | -966 M | -984 M | -898 M | -752 M | -407 M | -252 M | -39.7 M | -14.6 M | 77.8 M | 20 M | -34.9 M | -81.3 M | -117 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 77.8 M | -1.15 B | -433 M |
Quarterly Retained Earnings LivaNova PLC
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.18 B | -1.2 B | -1.23 B | -903 M | - | -992 M | -1.01 B | -966 M | -983 M | -976 M | -977 M | -984 M | -986 M | - | -895 M | -898 M | -880 M | -837 M | -782 M | -762 M | -752 M | -458 M | -752 M | -407 M | -407 M | -407 M | -407 M | -252 M | -252 M | -252 M | -252 M | -39.7 M | -39.7 M | -39.7 M | -39.7 M | -14.6 M | -14.6 M | -14.6 M | -14.6 M | 48.2 M | 48.2 M | 48.2 M | 48.2 M | - | - | - | 20 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 48.2 M | -1.23 B | -525 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 13.27 | -1.35 % | $ 1.79 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.3 | -0.15 % | $ 124 M |  France |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 25.74 | - | $ 218 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.64 | 6.67 % | $ 39.8 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 10.74 | -3.07 % | $ 304 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 89.45 | -1.39 % | $ 12.1 B | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.07 | -0.48 % | $ 1.26 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-802 M | $ 5.07 | -1.65 % | $ 1.07 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.23 | 0.41 % | $ 50 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 14.87 | -1.78 % | $ 349 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 10.31 | -2.27 % | $ 369 M | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 11.62 | -2.43 % | $ 460 M |  Curacao |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.03 | -0.96 % | $ 17.4 M | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 180.5 | -1.3 % | $ 12.7 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.61 | -0.49 % | $ 1.14 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 54.6 | -0.9 % | $ 1.6 B | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.29 | -1.12 % | $ 63.3 M | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 83.71 | -1.1 % | $ 2.91 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 81.55 | -0.89 % | $ 47.7 B | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.13 | -0.7 % | $ 5.91 M | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 315.23 | -1.95 % | $ 120 B | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 3.37 | -0.88 % | $ 498 M | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 22.99 | -2.46 % | $ 526 M | USA |
 |
TELA Bio
TELA
|
-398 M | $ 0.77 | -1.28 % | $ 36.1 M | USA |